Avery A. Thompson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Avery A. Thompson has a total of 97 co-authors. Here are the top co-authors by number of shared publications:
Nakul Raykar
Harvard Medical School Boston Massachusetts USA
5 shared publicationsAli Salim
Division of Trauma and Acute Care Surgery, Brigham and Women's Hospital, Boston, Massachusetts
3 shared publicationsEdward Mutebi
Lodwar County Referral Hospital, Blood Transfusion Services Lodwar Kenya
3 shared publicationsGeoffrey A. Anderson
Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, Massachusetts; Division of Trauma, Acute Care Surgery, and Critical Care, Los Angeles General Medical Center, University of Southern California, Los Angeles, California
3 shared publications- Linda S. Barnes
Linda S Barnes Consulting, Seattle, WA, USA; University of Pittsburgh, Pittsburgh, PA, USA; Strathmore University, Nairobi, Kenya
3 shared publications Manuel Castillo-Angeles
Division of Trauma and Acute Care Surgery, Brigham and Women's Hospital, Boston, Massachusetts
3 shared publications
Latest Publications
- 8 September 2026
- Published by Wiley in Transfusion
- Vol. 66 (11) , 2144-2154
Optimizing blood resource allocation in Oklahoma: A geospatial analysis of available supply and potential networks of distribution
Background: Blood transfusion is essential for surgical, obstetric, oncologic, and trauma care, but availability may be limited in rural settings. We quantified O‐type red blood cell (RBC) availability, access times, and donor distribution across Oklahoma and surrounding areas in 2024. Methods: Using Esri ArcGIS Pro, we evaluated rural hospitals in Oklahoma and adjacent regions supplied by Our Blood Institute (OBI) in 2024. Hospitals were categorized by critical access designation and O‐type RBC inventory, distinguishing low‐stock from resuscitation ready facilities (≤2 and ≥4 units, respectively). Primary outcomes were geographic variation in RBC inventories and drive times to the nearest hospital stocking ≥2 and ≥4 O‐type units. The secondary outcome was donor distribution. Results: Among 106 rural OBI‐supplied hospitals, 16 (15.1%) stocked <2 units O‐type RBCs, and 23% of rural critical access hospitals stocked 30 min from any hospital stocking O‐type RBCs, and 275,341 (4.0%) from one stocking ≥4 units. Of 245,068 donors, 40.87% were O+ and 8.59% were O−, with clustering that left several low‐stock rural areas with limited donor pools. Conclusion: Most rural OBI‐supplied hospitals maintained adequate O‐type RBC inventories, but a clinically significant minority stocked ≤2 units, insufficient for even a single hemorrhaging patient. Geographic variation in inventory and donor distribution means hemorrhage location remains a determinant of transfusion access. These findings support using local inventory and donor data to inform regional blood allocation, and identify translation of geospatial data into distribution and preparedness strategies as a priority for future research.
- 8 September 2026
- Published by Wiley in Transfusion
- Vol. 66 (11) , 2144-2154
Optimizing blood resource allocation in Oklahoma: A geospatial analysis of available supply and potential networks of distribution
Background: Blood transfusion is essential for surgical, obstetric, oncologic, and trauma care, but availability may be limited in rural settings. We quantified O‐type red blood cell (RBC) availability, access times, and donor distribution across Oklahoma and surrounding areas in 2024. Methods: Using Esri ArcGIS Pro, we evaluated rural hospitals in Oklahoma and adjacent regions supplied by Our Blood Institute (OBI) in 2024. Hospitals were categorized by critical access designation and O‐type RBC inventory, distinguishing low‐stock from resuscitation ready facilities (≤2 and ≥4 units, respectively). Primary outcomes were geographic variation in RBC inventories and drive times to the nearest hospital stocking ≥2 and ≥4 O‐type units. The secondary outcome was donor distribution. Results: Among 106 rural OBI‐supplied hospitals, 16 (15.1%) stocked <2 units O‐type RBCs, and 23% of rural critical access hospitals stocked 30 min from any hospital stocking O‐type RBCs, and 275,341 (4.0%) from one stocking ≥4 units. Of 245,068 donors, 40.87% were O+ and 8.59% were O−, with clustering that left several low‐stock rural areas with limited donor pools. Conclusion: Most rural OBI‐supplied hospitals maintained adequate O‐type RBC inventories, but a clinically significant minority stocked ≤2 units, insufficient for even a single hemorrhaging patient. Geographic variation in inventory and donor distribution means hemorrhage location remains a determinant of transfusion access. These findings support using local inventory and donor data to inform regional blood allocation, and identify translation of geospatial data into distribution and preparedness strategies as a priority for future research.
- 21 August 2026
- Published by Elsevier in Journal of Surgical Research
- Vol. 326, 954-962
Functional Limitations and Caregiver Need After Traumatic Injury: A Multi-Institutional Study
- 21 August 2026
- Published by Elsevier in Journal of Surgical Research
- Vol. 326, 954-962
Functional Limitations and Caregiver Need After Traumatic Injury: A Multi-Institutional Study
- Open Access
- 5 August 2026
- Published by Elsevier in Current Problems in Surgery
- Vol. 83
Temporary abdominal closure in emergency general surgery: A Scoping review of literature from 2015 to 2024
- 5 August 2026
- Published by Elsevier in Current Problems in Surgery
- Vol. 83
Open AccessTemporary abdominal closure in emergency general surgery: A Scoping review of literature from 2015 to 2024
- 27 April 2026
- Published by Wiley in Vox Sanguinis
- Vol. 121 (7) , 1093-1096
Life, death and rapid diagnostic tests in the world's blood deserts
Background and Objectives: Millions of people globally reside in ‘blood deserts’, where systemic barriers prevent timely access to safe blood components. Lodwar County Referral Hospital (LCRH) in Turkana County, Kenya, is a district hospital lacking on‐site testing capacity for transfusion‐transmissible infection (TTI) screening, resulting in critical transfusion delays. We present three cases in which validated rapid diagnostic tests (RDTs) could have facilitated point‐of‐care donor screening and transfusion in life‐threatening situations. Patients and Methods: We present three cases of critically ill patients—two teenagers and an elderly woman—who presented to LCRH over the course of a single week. Results: Each patient required emergent transfusions but experienced fatal delays along various points in the transfusion continuum due to the inability to rapidly screen available donor or banked blood for TTIs. Conclusion: These cases illustrate how delays in TTI screening can directly contribute to preventable mortality, even when blood is otherwise available. They highlight the urgent need for standardized, contextually appropriate emergency transfusion protocols that formally incorporate RDT use. Our experience suggests that such protocols may reduce transfusion delays, improve access to lifesaving blood and serve as a scalable model for improving blood access in rural and remote ‘blood deserts’ around the world.
- 27 April 2026
- Published by Wiley in Vox Sanguinis
- Vol. 121 (7) , 1093-1096
Life, death and rapid diagnostic tests in the world's blood deserts
Background and Objectives: Millions of people globally reside in ‘blood deserts’, where systemic barriers prevent timely access to safe blood components. Lodwar County Referral Hospital (LCRH) in Turkana County, Kenya, is a district hospital lacking on‐site testing capacity for transfusion‐transmissible infection (TTI) screening, resulting in critical transfusion delays. We present three cases in which validated rapid diagnostic tests (RDTs) could have facilitated point‐of‐care donor screening and transfusion in life‐threatening situations. Patients and Methods: We present three cases of critically ill patients—two teenagers and an elderly woman—who presented to LCRH over the course of a single week. Results: Each patient required emergent transfusions but experienced fatal delays along various points in the transfusion continuum due to the inability to rapidly screen available donor or banked blood for TTIs. Conclusion: These cases illustrate how delays in TTI screening can directly contribute to preventable mortality, even when blood is otherwise available. They highlight the urgent need for standardized, contextually appropriate emergency transfusion protocols that formally incorporate RDT use. Our experience suggests that such protocols may reduce transfusion delays, improve access to lifesaving blood and serve as a scalable model for improving blood access in rural and remote ‘blood deserts’ around the world.
- 14 April 2026
- Published by Wiley in Transfusion
- Vol. 66 (7) , 1326-1335
Geographic variation in blood transfusion among TRICARE beneficiaries
Background: Blood is a critical but inconsistently distributed resource. Within the United States, there are known state‐level variations in blood product distribution; however, little is known about geographic variations in transfusion practices on a national level. The US Military Health System offers an opportunity to study a nationally representative population through the TRICARE insurance claims database. Study design and methods: Claims from beneficiaries with acute bleeding diagnoses (related to trauma, postpartum hemorrhage, or gastrointestinal bleeding) from 2017 to 2022 were analyzed. Multivariable logistic regressions were used to examine relationships between geographic characteristics (hospital region and rurality) and transfusion status. Results: The study population consisted of 87,034 admissions. In adjusted models, rural trauma patients were significantly less likely to be transfused than urban trauma patients (aOR 0.18, 0.03–0.55). Conversely, rural postpartum hemorrhage and gastrointestinal bleeding patients were more likely to be transfused than their urban counterparts (aOR 1.63, 1.32–2.00 and aOR 1.24, 1.11–1.37, respectively). Hospital region was significantly associated with transfusion status among the postpartum hemorrhage and gastrointestinal bleeding cohorts, with patients in the Midwest less likely to receive a transfusion than patients in the Northeast (aOR 0.33, 0.24–0.45 and aOR 0.60, 0.52–0.70, respectively). Discussion: In this sample, geographic factors including hospital region and rurality were independently associated with transfusion status among inpatients with acute bleeding diagnoses. These variations may reflect provider‐ or system‐level factors and can help identify areas of potential vulnerability.
- 14 April 2026
- Published by Wiley in Transfusion
- Vol. 66 (7) , 1326-1335
Geographic variation in blood transfusion among TRICARE beneficiaries
Background: Blood is a critical but inconsistently distributed resource. Within the United States, there are known state‐level variations in blood product distribution; however, little is known about geographic variations in transfusion practices on a national level. The US Military Health System offers an opportunity to study a nationally representative population through the TRICARE insurance claims database. Study design and methods: Claims from beneficiaries with acute bleeding diagnoses (related to trauma, postpartum hemorrhage, or gastrointestinal bleeding) from 2017 to 2022 were analyzed. Multivariable logistic regressions were used to examine relationships between geographic characteristics (hospital region and rurality) and transfusion status. Results: The study population consisted of 87,034 admissions. In adjusted models, rural trauma patients were significantly less likely to be transfused than urban trauma patients (aOR 0.18, 0.03–0.55). Conversely, rural postpartum hemorrhage and gastrointestinal bleeding patients were more likely to be transfused than their urban counterparts (aOR 1.63, 1.32–2.00 and aOR 1.24, 1.11–1.37, respectively). Hospital region was significantly associated with transfusion status among the postpartum hemorrhage and gastrointestinal bleeding cohorts, with patients in the Midwest less likely to receive a transfusion than patients in the Northeast (aOR 0.33, 0.24–0.45 and aOR 0.60, 0.52–0.70, respectively). Discussion: In this sample, geographic factors including hospital region and rurality were independently associated with transfusion status among inpatients with acute bleeding diagnoses. These variations may reflect provider‐ or system‐level factors and can help identify areas of potential vulnerability.
- 18 November 2025
- Published by Wiley in Vox Sanguinis
- Vol. 121 (3) , 222-227
The critical role of tranexamic acid for bleeding patients
Tranexamic acid (TXA) is an essential life‐saving medicine that prevents clot breakdown in patients who are haemorrhaging from trauma, childbirth, surgery and other causes. While TXA is inexpensive, it is not widely used, especially in low‐ and middle‐income countries, which also experience challenges in the domains of blood collection, testing, storage and transfusion. TXA has been extensively studied for the treatment of traumatic, obstetric and surgical bleeding, and landmark trials have repeatedly demonstrated its safety, efficacy and life‐saving potential, especially when given early (within 3 h of the inciting event). Among trauma patients with blunt and penetrating injuries as well as head trauma, TXA decreases the risk of mortality and is also cost effective. Among women with postpartum haemorrhage, TXA decreases the risk of death due to bleeding, and has been successfully implemented as part of a bundled response. Among surgical patients across sub‐specialties, TXA decreases the risk of mortality and even decreases the need for blood product transfusion. Furthermore, these trials have shown that TXA does not increase the risk of adverse events such as thrombosis or seizure. We encourage the global community to shift its focus from further trials to the development of standardized implementation protocols, which have been shown to increase TXA use in both high‐ and low‐resource settings. Expansion of TXA availability and use in global blood deserts will help bridge the gap for haemorrhaging patients who are at risk of death and disability from injury, childbirth or surgical bleeding.
- 18 November 2025
- Published by Wiley in Vox Sanguinis
- Vol. 121 (3) , 222-227
The critical role of tranexamic acid for bleeding patients
Tranexamic acid (TXA) is an essential life‐saving medicine that prevents clot breakdown in patients who are haemorrhaging from trauma, childbirth, surgery and other causes. While TXA is inexpensive, it is not widely used, especially in low‐ and middle‐income countries, which also experience challenges in the domains of blood collection, testing, storage and transfusion. TXA has been extensively studied for the treatment of traumatic, obstetric and surgical bleeding, and landmark trials have repeatedly demonstrated its safety, efficacy and life‐saving potential, especially when given early (within 3 h of the inciting event). Among trauma patients with blunt and penetrating injuries as well as head trauma, TXA decreases the risk of mortality and is also cost effective. Among women with postpartum haemorrhage, TXA decreases the risk of death due to bleeding, and has been successfully implemented as part of a bundled response. Among surgical patients across sub‐specialties, TXA decreases the risk of mortality and even decreases the need for blood product transfusion. Furthermore, these trials have shown that TXA does not increase the risk of adverse events such as thrombosis or seizure. We encourage the global community to shift its focus from further trials to the development of standardized implementation protocols, which have been shown to increase TXA use in both high‐ and low‐resource settings. Expansion of TXA availability and use in global blood deserts will help bridge the gap for haemorrhaging patients who are at risk of death and disability from injury, childbirth or surgical bleeding.
- 14 November 2025
- Published by Wiley in Transfusion
- Vol. 65 (12) , 2293-2305
The local initiative for emergency blood ( LIFE ‐blood) study: A mixed‐methods, single‐center exploration of civilian walking blood bank need, feasibility, and safety in a low‐resource blood desert
Background: Billions live in blood deserts, regions where there is effectively no access to blood transfusions. Lodwar County Referral Hospital, set in a rural, low‐resource area in northwestern Kenya, is located in one such blood desert. A walking blood bank is a point‐of‐care system of emergency transfusion when banked blood is unavailable. The objective of this study was to evaluate the need, feasibility, and safety of a walking blood bank to address blood unavailability in a low‐resource, civilian setting. Study Design and Methods: This was a mixed‐methods study. Blood need was determined through chart review from April to July 2022. Feasibility was evaluated through qualitative interviews with hospital stakeholders. Safety was established by comparing the diagnostic performance of rapid diagnostic testing to standard‐of‐care assays for transfusion‐transmitted infections (HIV, HBV, HCV, syphilis). Results: Stockouts occurred 40 of 126 days (32%). Stakeholders acknowledged blood was frequently unavailable and it was sometimes necessary to perform emergency transfusion using rapid tests to screen blood in order to save a life, despite uncertainty over their performance to detect transfusion infections. Overall transfusion infection prevalence in donors was 5.4%. Rapid testing had a 99.2% ( p = .01) negative predictive value when compared against standard‐of‐care laboratory‐based tests. Discussion: A walking blood bank for emergency transfusion that uses rapid diagnostic testing may serve as a feasible and safe stopgap measure to address hemorrhagic shock and severe anemia in the world's blood deserts.
- 14 November 2025
- Published by Wiley in Transfusion
- Vol. 65 (12) , 2293-2305
The local initiative for emergency blood ( LIFE ‐blood) study: A mixed‐methods, single‐center exploration of civilian walking blood bank need, feasibility, and safety in a low‐resource blood desert
Background: Billions live in blood deserts, regions where there is effectively no access to blood transfusions. Lodwar County Referral Hospital, set in a rural, low‐resource area in northwestern Kenya, is located in one such blood desert. A walking blood bank is a point‐of‐care system of emergency transfusion when banked blood is unavailable. The objective of this study was to evaluate the need, feasibility, and safety of a walking blood bank to address blood unavailability in a low‐resource, civilian setting. Study Design and Methods: This was a mixed‐methods study. Blood need was determined through chart review from April to July 2022. Feasibility was evaluated through qualitative interviews with hospital stakeholders. Safety was established by comparing the diagnostic performance of rapid diagnostic testing to standard‐of‐care assays for transfusion‐transmitted infections (HIV, HBV, HCV, syphilis). Results: Stockouts occurred 40 of 126 days (32%). Stakeholders acknowledged blood was frequently unavailable and it was sometimes necessary to perform emergency transfusion using rapid tests to screen blood in order to save a life, despite uncertainty over their performance to detect transfusion infections. Overall transfusion infection prevalence in donors was 5.4%. Rapid testing had a 99.2% ( p = .01) negative predictive value when compared against standard‐of‐care laboratory‐based tests. Discussion: A walking blood bank for emergency transfusion that uses rapid diagnostic testing may serve as a feasible and safe stopgap measure to address hemorrhagic shock and severe anemia in the world's blood deserts.
- Open Access
A Protocol to Implement and Evaluate a Community Walking Blood Bank for Hemorrhagic Shock When Banked Blood is Unavailable - The Local Initiative For Emergency Blood (LIFE-Blood) Study, Phase 2
Introduction Trauma, obstetric hemorrhage, and severe anemia lead to millions of deaths every year. The majority of these deaths occur in regions known as “blood deserts” where there is virtually no access to blood transfusions. Currently, these blood deserts have minimal resources to improve access to this life-saving medicine. A community walking blood bank (CWBB) is a low-resource strategy that can provide just-in-time, point-of-care, tested blood transfusion in blood deserts when banked blood is not readily available and the alternative is almost-certain death. This protocol is designed to evaluate the effectiveness and implementation of a CWBB at Lodwar County Referral Hospital (LCRH) located in a blood desert in rural northwest Kenya. Methods We will use a mixed methods approach relying on an implementation science design to look at effectiveness, acceptability, applicability, and impact of a CWBB. First, a previously developed emergency transfusion protocol will be validated and finalized by key hospital stakeholders. Effectiveness will be assessed 1) quantitatively, using prospective laboratory-based data collection before and after protocol initiation to measure changes in blood ordering practices and 2) qualitatively, through key informant interviews of hospital staff and the community focusing on clinical blood demand and general understanding and perceptions about blood donation and transfusion. Lastly, we will determine the adaptability and scalability of a CWBB to other low-resource settings with in-depth interviews, and a modified Delphi approach to achieve consensus regarding key components of a CWBB and its transferability to other settings. Ethics and dissemination The study has received ethical approval by Strathmore University and Mass General Brigham. The research will guide the development of civilian walking blood banks to provide just-in-time blood transfusion for emergencies in blood deserts, when banked, screened blood is unavailable. Study findings will be disseminated within Kenya, to the ministry of health and national blood transfusion service, and internationally through peer-reviewed publications and conferences.
Open AccessA Protocol to Implement and Evaluate a Community Walking Blood Bank for Hemorrhagic Shock When Banked Blood is Unavailable - The Local Initiative For Emergency Blood (LIFE-Blood) Study, Phase 2
Introduction Trauma, obstetric hemorrhage, and severe anemia lead to millions of deaths every year. The majority of these deaths occur in regions known as “blood deserts” where there is virtually no access to blood transfusions. Currently, these blood deserts have minimal resources to improve access to this life-saving medicine. A community walking blood bank (CWBB) is a low-resource strategy that can provide just-in-time, point-of-care, tested blood transfusion in blood deserts when banked blood is not readily available and the alternative is almost-certain death. This protocol is designed to evaluate the effectiveness and implementation of a CWBB at Lodwar County Referral Hospital (LCRH) located in a blood desert in rural northwest Kenya. Methods We will use a mixed methods approach relying on an implementation science design to look at effectiveness, acceptability, applicability, and impact of a CWBB. First, a previously developed emergency transfusion protocol will be validated and finalized by key hospital stakeholders. Effectiveness will be assessed 1) quantitatively, using prospective laboratory-based data collection before and after protocol initiation to measure changes in blood ordering practices and 2) qualitatively, through key informant interviews of hospital staff and the community focusing on clinical blood demand and general understanding and perceptions about blood donation and transfusion. Lastly, we will determine the adaptability and scalability of a CWBB to other low-resource settings with in-depth interviews, and a modified Delphi approach to achieve consensus regarding key components of a CWBB and its transferability to other settings. Ethics and dissemination The study has received ethical approval by Strathmore University and Mass General Brigham. The research will guide the development of civilian walking blood banks to provide just-in-time blood transfusion for emergencies in blood deserts, when banked, screened blood is unavailable. Study findings will be disseminated within Kenya, to the ministry of health and national blood transfusion service, and internationally through peer-reviewed publications and conferences.
- 1 September 2021
- Published by Elsevier in The American Journal of Surgery
- Vol. 222 (3) , 501-503
Paying it forward: A pilot program for near-peer support for medical students during the surgery clerkship
- 1 September 2021
- Published by Elsevier in The American Journal of Surgery
- Vol. 222 (3) , 501-503
Paying it forward: A pilot program for near-peer support for medical students during the surgery clerkship